Investors are targeting consumer brands with strong fundamentals or overlooked expansion angles as part of efforts to avert spiking valuations, the AVCJ Private Equity & Venture Forum heard.
There is a tendency to chase after companies that have experienced a rapid increase in growth momentum, which results in a faddish VC-style bandwagon where a more measured growth capital approach is needed,...
India’s Innoven Capital, a joint venture between UOB and Temasek Holdings-owned Seviora Holdings, has fractionalised a USD 50m venture debt fund using blockchain and smart contracts.
OneVentures and UniQuest have led a AUD 34m (USD 23m) funding round for Vaxxas, an Australia-based biotechnology company running clinical programmes that include a needle-free COVID-19 vaccine candidate.
Temasek Holdings, A91 Partners, and Kae Capital have invested USD 135m in Indian omnichannel wellness products retailer HealthKart.